StageZero Life Sciences Ltd.
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.04-10.84-0.19-2.56-4.96-1.27-2.42-3.67-2.18-0.38-2.16-4.96
Price/Sales ratio
217.0733.933.5514.3835.5326.9775.406.353.301.151.9726.97
Price/Book Value ratio
15.4533.27-0.65-3.20-4.85-1.03-2.32-21.386.07-0.586.32-4.85
Price/Cash Flow ratio
-6.21-46.69-0.67-4.11-3.82-1.52-2.27-8.60-1.87-1.24-1.59-3.82
Price/Free Cash Flow ratio
-5.52-46.59-0.67-4.11-3.82-1.52-2.25-8.41-1.84-1.24-1.59-3.82
Price/Earnings Growth ratio
0.420.230.000.120.070.300.05-0.150.06N/A-0.010.30
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%-39.34%-241.14%-580.67%-692.77%16.75%23.23%-10.63%-0.56%-241.14%
Operating Profit Margin
-5737.72%-313.00%-1855.13%-404.56%-946.53%-2343.02%-3686.23%-89.09%-160.43%-204.12%-197.09%-946.53%
Pretax Profit Margin
-7119.98%-312.88%-1868.81%-560.75%-715.95%-2121.82%-2510.23%-165.32%-147.66%-300.79%-91.16%-715.95%
Net Profit Margin
-7119.98%-312.88%-1846.72%-560.75%-715.95%-2121.82%-3108.98%-173.04%-151.61%-300.79%-91.16%-715.95%
Effective Tax Rate
-20.74%-68.37%1.18%-9.68%39.86%39.06%-23.85%-4.66%-2.67%N/AN/A39.06%
Return on Assets
-295.15%-225.57%-1051.61%-171.74%-109.42%-158.66%-219.48%-84.44%-72.17%-1629.24%-50.12%-109.42%
Return On Equity
-506.95%-306.83%339.53%125.02%97.73%81.53%96.01%582.44%-278.23%152.13%-196.89%81.53%
Return on Capital Employed
-408.53%-306.94%341.31%147.43%444.84%143.74%226.84%-126.56%-137.78%122.46%-339.05%143.74%
Liquidity Ratios
Current Ratio
2.373.760.240.100.090.060.051.29N/AN/A0.070.06
Quick Ratio
2.323.870.250.080.070.040.031.220.410.020.010.04
Cash ratio
2.213.010.220.030.010.010.011.180.360.000.000.01
Days of Sales Outstanding
398.0973.75N/AN/AN/AN/A57.106.509.133.003.34N/A
Days of Inventory outstanding
N/AN/AN/A24.5522.2632.0129.1237.4838.358.3118.7232.01
Operating Cycle
N/AN/AN/A24.5522.2632.0186.2243.9947.4911.3119.5432.01
Days of Payables Outstanding
N/AN/AN/A630.78563.03587.00449.07132.3768.92245.27174.84587.00
Cash Conversion Cycle
N/AN/AN/A-606.23-540.77-554.99-362.84-88.38-21.43-233.95-166.88-540.77
Debt Ratios
Debt Ratio
0.08N/A2.300.870.581.290.860.340.082.290.820.58
Debt Equity Ratio
0.15N/A-0.74-0.63-0.52-0.66-0.37-2.400.34-0.214.81-0.52
Long-term Debt to Capitalization
N/AN/AN/A-0.11-0.59-0.37-0.14-0.880.17-0.080.30-0.59
Total Debt to Capitalization
0.13N/A-2.93-1.77-1.10-1.99-0.611.710.25-0.270.54-1.10
Interest Coverage Ratio
-4.16-402.44-63.92-12.48-22.85-3.86-6.39-10.47N/AN/A-44.32-3.86
Cash Flow to Debt Ratio
-16.58N/A-1.30-1.21-2.41-1.02-2.69-1.03-9.51-2.19-3.30-1.02
Company Equity Multiplier
1.711.36-0.32-0.72-0.89-0.51-0.43-6.893.85-0.095.81-0.89
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-34.94-0.72-5.29-3.49-9.28-17.70-33.09-0.73-1.76-0.92-1.23-9.28
Free Cash Flow / Operating Cash Flow Ratio
1.121.001.00111.001.001.021.0111.001
Cash Flow Coverage Ratio
-16.58N/A-1.30-1.21-2.41-1.02-2.69-1.03-9.51-2.19-3.30-1.02
Short Term Coverage Ratio
-16.58N/A-1.30-1.44-8.41-1.72-4.05-1.28-24.98-3.42-5.13-8.41
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A